Background: Cholestasis is a significant life‐threatening complication in children on
parenteral nutrition (PN). Strategies to prevent/treat PN‐associated cholestasis (PNAC) and …

This article summarizes the presentations given at an ESPEN Workshop on “Lipids in the
ICU” held in Tel Aviv, Israel in November 2014 and subsequent discussions and updates …

Background: Children with severe intestinal failure and prolonged dependence on
parenteral nutrition are susceptible to the development of parenteral nutrition–associated …

The currently available, standard soybean oil (SO)–based intravenous fat emulsions (IVFEs)
meet the needs of most parenteral nutrition (PN) patients. There are alternative oil‐based fat …

Intravenous supplementation (IVS) of parenteral nutrition (PN) admixtures and/or fluid and
electrolyte solutions is the primary treatment of intestinal failure (IF), defined as “the …

Intravenous lipid emulsions are an essential component of parenteral nutrition regimens.
Originally employed as an efficient non-glucose energy source to reduce the adverse effects …

OBJECTIVE: The aim of this study was to review evidence-based data addressing key
clinical questions regarding parenteral nutrition–associated cholestasis (PNAC) and …

Importance The introduction of hepatoprotective strategies and multidisciplinary
management has significantly improved the outcome of neonates with short bowel …

OBJECTIVE: To determine factors leading to resolution of cholestasis in patients with
parenteral nutrition-associated liver disease treated with fish oil-based lipid emulsion …

The essentiality of fatty acids was determined by the Burrs in the 1920s. It is commonly
accepted that provision of linoleic (LA) and alpha-linolenic acids (ALA) prevents and …